Inactive Instrument
Quotes Aviragen Therapeutics Inc Nasdaq
Stocks
US0906941002
Biotechnology & Medical Research
|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 08-08 | Vaxart, Inc., Q2 2026 Earnings Call, Aug 07, 2026 | |
| 08-07 | Vaxart, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Stock exchange
Nasdaq- $
-
0
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| VXRT | 0.6039USD | +0.63% | 25.22K $ |
Basic data
Market Cap (USD)
135,987,800
Net sales (USD)
237,258,000
Free-Float
98.56 %
Free-Float capitalization (USD)
134,098,967
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | 136M | |
| +2.07% | +13.76% | +65.44% | +106.53% | 71.56B | |
| -1.17% | -2.33% | +33.92% | +63.07% | 54.43B | |
| -4.50% | -4.69% | +2.82% | +463.22% | 27.59B | |
| -1.27% | -1.57% | +46.46% | +6.09% | 23.91B | |
| -0.67% | +1.02% | -18.32% | -13.84% | 23.14B | |
| +0.37% | +1.70% | +39.39% | -19.80% | 18.65B | |
| +0.35% | +12.02% | +257.19% | +466.50% | 18.64B | |
| -0.95% | -3.52% | +20.04% | +613.01% | 16.01B | |
| +0.46% | -3.05% | +31.49% | +135.18% | 12.54B | |
| Average | -0.59% | +4.06% | +53.16% | +202.22% | 26.66B | |
| Weighted average by Cap. | -0.31% | +3.63% | +50.81% | +163.23% |
Historical Quotes: Aviragen Therapeutics Inc
| Date | Opening | High | Low | Close | Volume | Change |
|---|
- Stock Market
- Stocks
- VXRT Stock
- Stock
- Quotes Aviragen Therapeutics Inc
Select your edition
All financial news and data tailored to specific country editions
